Literature DB >> 28380718

A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study.

Ganesh M Babulal1, Sarah H Stout1, Tammie L S Benzinger1, Brian R Ott2, David B Carr1, Mollie Webb1, Cindy M Traub1, Aaron Addison1, John C Morris1, David K Warren1, Catherine M Roe1.   

Abstract

A clinical consequence of symptomatic Alzheimer's disease (AD) is impaired driving performance. However, decline in driving performance may begin in the preclinical stage of AD. We used a naturalistic driving methodology to examine differences in driving behavior over one year in a small sample of cognitively normal older adults with ( n = 10) and without ( n = 10) preclinical AD. As expected with a small sample size, there were no statistically significant differences between the two groups, but older adults with preclinical AD drove less often, were less likely to drive at night, and had fewer aggressive behaviors such as hard braking, speeding, and sudden acceleration. The sample size required to power a larger study to determine differences was calculated.

Entities:  

Keywords:  Alzheimer’s disease; driving; naturalistic methodology; older adults

Mesh:

Year:  2017        PMID: 28380718      PMCID: PMC5555816          DOI: 10.1177/0733464817690679

Source DB:  PubMed          Journal:  J Appl Gerontol        ISSN: 0733-4648


  27 in total

1.  Factors affecting self-regulatory driving practices among older adults.

Authors:  Lisa J Molnar; Judith L Charlton; David W Eby; Jim Langford; Sjaan Koppel; Giselle E Kolenic; Shawn Marshall
Journal:  Traffic Inj Prev       Date:  2014       Impact factor: 1.491

2.  Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study.

Authors:  Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan
Journal:  Lancet Neurol       Date:  2013-09-04       Impact factor: 44.182

3.  The influence of Driving Status on Transportation Challenges Experienced by Older Adults.

Authors:  Lori E Weeks; Robin Stadnyk; Lorraine Begley; Dany J MacDonald
Journal:  J Appl Gerontol       Date:  2013-05-31

Review 4.  A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Megan A Hird; Peter Egeto; Corinne E Fischer; Gary Naglie; Tom A Schweizer
Journal:  J Alzheimers Dis       Date:  2016-05-11       Impact factor: 4.472

5.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

6.  Driving Cessation Anno 2010: Which Older Drivers Give Up Their License and Why? Evidence From Denmark.

Authors:  Anu Siren; Sonja Haustein
Journal:  J Appl Gerontol       Date:  2014-02-12

7.  The relationship between self-regulation and driving-related abilities in older drivers: an exploratory study.

Authors:  Lisa J Molnar; David W Eby
Journal:  Traffic Inj Prev       Date:  2008-08       Impact factor: 1.491

8.  Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.

Authors:  Catherine M Roe; Mark A Mintun; Gina D'Angelo; Chengjie Xiong; Elizabeth A Grant; John C Morris
Journal:  Arch Neurol       Date:  2008-11

9.  Creating a driving profile for older adults using GPS devices and naturalistic driving methodology.

Authors:  Ganesh M Babulal; Cindy M Traub; Mollie Webb; Sarah H Stout; Aaron Addison; David B Carr; Brian R Ott; John C Morris; Catherine M Roe
Journal:  F1000Res       Date:  2016-09-26

10.  Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease.

Authors:  Anne M Fagan; Mark A Mintun; Aarti R Shah; Patricia Aldea; Catherine M Roe; Robert H Mach; Daniel Marcus; John C Morris; David M Holtzman
Journal:  EMBO Mol Med       Date:  2009-11       Impact factor: 12.137

View more
  16 in total

1.  Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.

Authors:  Ganesh M Babulal; Suzie Chen; Monique M Williams; Jean-Francois Trani; Parul Bakhshi; Grace L Chao; Sarah H Stout; Anne M Fagan; Tammie L S Benzinger; David M Holtzman; John C Morris; Catherine M Roe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.

Authors:  Catherine M Roe; Ganesh M Babulal; Shruti Mishra; Brian A Gordon; Sarah H Stout; Brian R Ott; David B Carr; Beau M Ances; John C Morris; Tammie L S Benzinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Differences in Driving Outcomes Among Cognitively Normal African American and Caucasian Older Adults.

Authors:  Ganesh M Babulal; Sarah H Stout; Monique M Williams; Ganesh Rajasekar; Annie Harmon; Jonathon Vivoda; Megan Zuelsdorff; Tammie L S Benzinger; John C Morris; Beau Ances; Catherine M Roe
Journal:  J Racial Ethn Health Disparities       Date:  2019-11-04

4.  A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.

Authors:  Catherine M Roe; Sarah H Stout; Ganesh Rajasekar; Beau M Ances; Jessica M Jones; Denise Head; Tammie L S Benzinger; Monique M Williams; Jennifer Duncan Davis; Brian R Ott; David K Warren; Ganesh M Babulal
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Cognitive impairment and World Trade Centre-related exposures.

Authors:  Sean A P Clouston; Charles B Hall; Minos Kritikos; David A Bennett; Steven DeKosky; Jerri Edwards; Caleb Finch; William C Kreisl; Michelle Mielke; Elaine R Peskind; Murray Raskind; Marcus Richards; Richard P Sloan; Avron Spiro; Neil Vasdev; Robert Brackbill; Mark Farfel; Megan Horton; Sandra Lowe; Roberto G Lucchini; David Prezant; Joan Reibman; Rebecca Rosen; Kacie Seil; Rachel Zeig-Owens; Yael Deri; Erica D Diminich; Bernadette A Fausto; Sam Gandy; Mary Sano; Evelyn J Bromet; Benjamin J Luft
Journal:  Nat Rev Neurol       Date:  2021-11-18       Impact factor: 42.937

6.  Neuropsychological Correlates of Changes in Driving Behavior Among Clinically Healthy Older Adults.

Authors:  Andrew J Aschenbrenner; Samantha A Murphy; Jason M Doherty; Ann M Johnson; Sayeh Bayat; Alexis Walker; Yasmin Peña; Jason Hassenstab; John C Morris; Ganesh M Babulal
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-10-06       Impact factor: 4.942

7.  Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.

Authors:  Jason M Doherty; Catherine M Roe; Samantha A Murphy; Ann M Johnson; Ella Fleischer; Cristina D Toedebusch; Tiara Redrick; David Freund; John C Morris; Suzanne E Schindler; Anne M Fagan; David M Holtzman; Brendan P Lucey; Ganesh M Babulal
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

8.  Reaction to a Pandemic: Social Distancing and Driving Among Older Adults During COVID-19.

Authors:  Catherine M Roe; Christopher B Rosnick; Angela Colletta; Ganesh M Babulal
Journal:  J Appl Gerontol       Date:  2020-10-14

9.  Using Naturalistic Driving Data to Predict Mild Cognitive Impairment and Dementia: Preliminary Findings from the Longitudinal Research on Aging Drivers (LongROAD) Study.

Authors:  Xuan Di; Rongye Shi; Carolyn DiGuiseppi; David W Eby; Linda L Hill; Thelma J Mielenz; Lisa J Molnar; David Strogatz; Howard F Andrews; Terry E Goldberg; Barbara H Lang; Minjae Kim; Guohua Li
Journal:  Geriatrics (Basel)       Date:  2021-04-23

10.  GPS driving: a digital biomarker for preclinical Alzheimer disease.

Authors:  Sayeh Bayat; Ganesh M Babulal; Suzanne E Schindler; Anne M Fagan; John C Morris; Alex Mihailidis; Catherine M Roe
Journal:  Alzheimers Res Ther       Date:  2021-06-14       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.